Pandemic H1N1 influenza A directly induces a robust and acute inflammatory gene signature in primary human bronchial epithelial cells downstream of membrane fusion

Virology

Volumn 448, Issue , 2014, Pages 91-103

  Paquette, Stéphane G ^a,b   Banner, David ^a   Chi, Le Thi Bao ^c   Leon, Alberto J ^a,d   Xu, Luoling ^a   Ran, Longsi ^a   Huang, Stephen S H ^a,b   Farooqui, Amber ^a,d   Kelvin, David J ^a,b,d,e,f   Kelvin, Alyson A ^e  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HUE UNIVERSITY   (Viet Nam)

^d SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^e Immune Diagnostics and Research   (Canada)

^f UNIVERSITY OF SASSARI   (Italy)

Author keywords

Epithelial cells; Inflammation; Inflammatory cytokines; Influenza; Membrane fusion; Pandemic H1N1; Virus entry

Indexed keywords

CXCL1 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; VIRUS RNA;

2009 H1N1 INFLUENZA; ARTICLE; BRONCHUS MUCOSA; CELL FUNCTION; CONTROLLED STUDY; DISEASE ACTIVITY; GENE EXPRESSION; GENE INDUCTION; GENE STRUCTURE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; MEMBRANE FUSION; MOLECULAR MECHANICS; MUCOSA CELL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SEASONAL INFLUENZA; VIRION; VIRUS CELL INTERACTION; VIRUS ENTRY;

EID: 84886256868     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.09.022     Document Type: Article

References (79)

1. Akira S., Takeda K. Toll-like receptor signaling. Nature Reviews Immunology 2004, 4:499-511.
2. Bals R., Hiemstra P. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. European Respiratory Journal 2004, 23:327-333.
3. Bautista E., Chotpitayasunondh T, Gao Z., Harper S.A., Shaw M., Uyeki T.M., Zaki S.R., Hayden F.G., Hui D.S., Kettner J.D., Kumar A., Lim M., Shindo N., Penn C., Nicholson K.G. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. New England Journal of Medicine 2010, 362:1708-1719.
4. Bermejo-Martin J.F., Ortiz de Lejarazu R., Pumarola T., Rello J., Almansa R., Ramírez P., Martin-Loeches I., Varillas D., Gallegos M.C., Serón C., Micheloud D., Gomez J.M., Tenorio-Abreu A., Ramos M.J., Molina M.L., Huidobro S., Sanchez E., Górdon M., Fernández V., del Castillo A., Marcos M.Á., Villanueva B., López C.J., Rodríguez-Domínguez M., Galan J.-C., Cantón R., Lietor A., Rojo S., Eiros J.M., Hinojosa C., Gonzalez I., Torner N., Banner D., Leon A., Cuesta P., Rowe T., Kelvin D.J. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Critical Care 2009, 13:R201.
5. Budimir N., Huckriede A., Meijerhof T., Boon L., Gostick E., Price D.A., Wilschut J., de Haan A. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity. PLoS One 2012, 7:e30898.
6. Chan M., Cheung C., Chui W., Tsao S., Nicholls J., Chan Y., Chan R., Long H., Poon L., Guan Y., Peiris J. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respiratory Research 2005, 6:135.
7. Chan M.C., Chan R.W., Yu W.C., Ho CC, Yuen K.M., Fong J.H., Tang LL, Lai W.W., Lo A.C., Chui W., Sihoe A.D., Kwong D.L., Wong D.S., Tsao G.S., Poon L.L., Guan Y, Nicholls J.M., Peiris J.S. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. American Journal of Pathology 2010, 176:1828-1840.
8. Childs R.A., Palma A.S., Wharton S., Matrosovich T., Liu Y., Chai W., Campanero-Rhodes M.A., Zhang Y., Eickmann M., Kiso M., Hay A., Matrosovich M., Feizi T. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nature Biotechnol 2009, 27:797-799.
9. Cho J.L., Roche M.I., Sandall B., Brass A.L., Seed B., Xavier R.J., Medoff BD. Enhanced Tim3 activity improves survival after influenza infection. Journal of Immunology 2012, 189:2879-2889.
10. Chustz R.T., Nagarkar D.R., Poposki J.A., Favoreto S., Avila P.C., Schleimer R.P., Kato A. Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells. American Journal of Respiratory Cell and Molecular Biology 2011, 45:145.
11. Davis W.G., Bowzard J.B., Sharma S.D., Wiens M.E., Ranjan P., Gangappa S., Stuchlik O., Pohl J., Donis R.O., Katz J.M., Cameron C.E., Fujita T., Sambhara S. The 3' untranslated regions of influenza genomic sequences are 5' PPP-independent ligands for RIG-I. PLoS One 2012, 7:e32661.
12. Dinwiddie D.L., Harrod K.S. Human metapneumovirus inhibits IFN-α signaling through inhibition of STAT1 phosphorylation. American Journal of Respiratory Cell and Molecular Biology 2008, 38:661-670.
13. Ehrhardt C., Marjuki H., Wolff T., Nürnberg B., Planz O., Pleschka S., Ludwig S. Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cellular Microbiology 2006, 8:1336-1348.
14. Eierhoff T., Hrincius E.R., Rescher U., Ludwig S., Ehrhardt C. The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathogen 2010, 6:e1001099.
15. Escaffre O., Borisevich V., Carmical J.R., Prusak D., Prescott J., Feldmann H., Rockx B. Henipavirus pathogenesis in human respiratory epithelial cells. Journal of Virology 2013, 87:3284-3294.
16. Fang Y., Banner D., Kelvin A.A., Huang S.S., Paige C.J., Corfe S.A., Kane K.P., Bleackley RC, Rowe T., Leon AJ, Kelvin D.J. Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism. Journal of Virology 2012, 86:2229-2238.
17. Frisullo G., Iorio R., Plantone D., Nociti V., Patanella A.K., Marti A., Palermo C., Valentini P., Mariotti P., Batocchi A.P. Involvement of type I immune responses in swine-origin H1N1 influenza virus infection. Human Immunology 2011, 72:632-635.
18. García M., Gil J., Ventoso I., Guerra S., Domingo E., Rivas C., Esteban M. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiology and Molecular Biology Reviews 2006, 70:1032-1060.
19. Gern J.E., French D.A., Grindle K.A., Brockman-Schneider R.A., Konno S.-I., Busse W.W. Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelial cells. American Journal of Respiratory Cell and Molecular Biology 2003, 28:731-737.
20. Gilsdorf A., Poggensee G. Influenza A (H1N1) v in Germany: the first 10,000 cases. Euro Surveillance 2009, 14.
21. Govorkova E.A., Baranovich T., Seiler P., Armstrong J., Burnham A., Guan Y., Peiris M., Webby R.J., Webster R.G. Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring. Antiviral Research 2013, 98:297-304.
22. Guillot L., Le Goffic R., Bloch S., Escriou N., Akira S., Chignard M., Si-Tahar M. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. Journal of Biological Chemistry 2005, 280:5571-5580.
23. Hayden F.G. Newer influenza antivirals, biotherapeutics and combinations. Influenza and Other Respiratory Viruses 2013, 7:63-75.
24. Helferty M., Vachon J., Tarasuk J., Rodin R., Spika J., Pelletier L. Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. Canadian Medical Association Journal 2010, 182:1981-1987.
25. Holm C.K., Jensen S.B., Jakobsen M.R., Cheshenko N., Horan K.A., Moeller H.B., Gonzalez-Dosal R., Rasmussen S.B., Christensen M.H., Yarovinsky T.O., Rixon F.J., Herold B.C., Fitzgerald K.A., Paludan S.R. Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nature Immunology 2012, 13:737-743.
26. Huang S.S., Banner D., Fang Y., Ng D.C., Kanagasabai T., Kelvin D.J., Kelvin A.A. Comparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B infections depict distinct clinical pictures in ferrets. PLoS One 2011, 6:e27512.
27. Huang S.S., Banner D., Degousee N., Leon A.J., Xu L., Paquette S.G., Kanagasabai T., Fang Y., Rubino S., Rubin B., Kelvin D.J., Kelvin A.A. Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection. Journal of Virology 2012, 86:13187-13201.
28. Huang S.S., Lin Z., Banner D., León A.J., Paquette S.G., Rubin B., Rubino S., Guan Y., Kelvin D.J., Kelvin A.A. Immunity toward H1N1 influenza hemagglutinin of historical and contemporary strains suggests protection and vaccine failure. Scientific Reports 2013, 3:1698.
29. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocol 2008, 4:44-57.
30. Huang da W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research 2009, 37:1-13.
31. Hui D.S., Lee N, Chan P.K. Clinical management of pandemic 2009 influenza A (H1N1) infection. Chest 2010, 137:916-925.
32. Hui KP, Lee SM, Cheung C-y, Mao H., Lai A.K., Chan R.W., Chan M.C., Tu W., Guan Y., Lau Y.-L., Peiris J. H5N1 influenza virus-induced mediators upregulate RIG-I in uninfected cells by paracrine effects contributing to amplified cytokine cascades. Journal of Infectious Diseases 2011, 204:1866-1878.
33. Ichinohe T., Pang I.K., Iwasaki A. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nature Immunology 2010, 11:404-410.
34. Itoh Y., Shinya K., Kiso M., Watanabe T., Sakoda Y, Hatta M., Muramoto Y., Tamura D., Sakai-Tagawa Y., Noda T., Sakabe S., Imai M., Hatta Y., Watanabe S., Li C., Kakugawa S., Ito M., Takano R., Iwatsuki-Horimoto K., Shimojima M., Horimoto T., Goto H., Takahashi K., Makino A., Ishigaki H., Nakayama M., Okamatsu M., Takahashi K., Warshauer D., Shult P.A., Saito R., Suzuki H., Furuta Y., Yamashita M., Mitamura K., Nakano K., Nakamura M., Brockman-Schneider R., Mitamura H., Yamazaki M., Sugaya N., Suresh M., Ozawa M., Neumann G., Gern J., Kida H., Ogasawara K, Kawaoka Y. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009, 460:1021-1025.
35. Kato A., Schleimer R.P. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Current Opinion Immunology 2007, 19:711-720.
36. Kumar A., Zarychanski R., Pinto R., Cook DJ, Marshall J., Lacroix J., Stelfox T., Bagshaw S., Choong K., Lamontagne F., Turgeon A.F., Lapinsky S., Ahern S.P., Smith O., Siddiqui F., Jouvet P., Khwaja K., McIntyre L., Menon K., Hutchison J., Hornstein D., Joffe A., Lauzier F., Singh J., Karachi T., Wiebe K., Olfason K., Ramsey C., Sharma S., Dodek P., Meade M., Hall R., Fowler R.A. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. Journal of the American Medical Association 2009, 302:1872-1879.
37. Lakadamyali M., Rust M.J., Zhuang X. Endocytosis of influenza viruses. Microbes and Infection 2004, 6:929-936.
38. Le Goffic R., Pothlichet J., Vitour D., Fujita T., Meurs E., Chignard M., Si-Tahar M. Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. Journal of Immunology 2007, 178:3368-3372.
39. Lee N., Chan P., Wong CK, Wong K-T, Choi K.-W., Joynt G.M., Lam P., Chan M., Wong B., Lui G., Sin W.W., Wong R.Y., Lam W.-Y., Yeung A.C., Leung T.-F., So H-Y, Yu A.W., Sung J.J., Hui D.S. Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A (H1N1) virus pneumonia. Antiviral Therapy 2011, 16:237.
40. Lee N, Wong C.K., Chan PK, Chan MC, Wong RY, Lun SW, Ngai K.L., Lui G.C., Wong B.C., Lee S.K. Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLoS One 2011, 6:e26050.
41. León A.J., Banner D., Xu L., Ran L., Peng Z., Yi K., Chen C., Xu F., Huang J., Zhao Z., Lin Z., Huang S.S., Fang Y., Kelvin A.A., Ross T.M., Farooqui A., Kelvin D.J. Sequencing, annotation, and characterization of the influenza ferret infectome. Journal of Virology 2013, 87:1957-1966.
42. Liu W.-C., Lin S.-C., Yu Y.-L., Chu C.-L., Wu S.-C. Dendritic cell activation by recombinant hemagglutinin proteins of H1N1 and H5N1 influenza A viruses. Journal of Virology 2010, 84:12011-12017.
43. Marcelin G., Aldridge J.R., Duan S., Ghoneim H.E., Rehg J., Marjuki H., Boon A.C., McCullers J.A., Webby R.J. Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice. Journal of Virology 2011, 85:11208-11219.
44. Marchant D., Singhera G.K., Utokaparch S., Hackett T.L., Boyd J.H., Luo Z., Si X., Dorscheid D.R., McManus B.M., Hegele R.G. Toll-like receptor 4-mediated activation of p38 mitogen-activated protein kinase is a determinant of respiratory virus entry and tropism. Journal of Virology 2010, 84:11359-11373.
45. Marjuki H., Alam M.I., Ehrhardt C., Wagner R., Planz O., Klenk H.-D., Ludwig S., Pleschka S. Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Cα-mediated activation of ERK signaling. Journal of Biological Chemistry 2006, 281:16707-16715.
46. Matsukura S., Kokubu F., Kurokawa M., Kawaguchi M., Ieki K., Kuga H., Odaka M., Suzuki S., Watanabe S., Takeuchi H., Kasama T., Adachi M. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-κB and/or IRF-3 in airway epithelial cells. Clinical and Experimental Allergy 2006, 36:1049-1062.
47. Mauad T., Hajjar L., Callegari G., da Silva L., Schout D., Galas F., Alves V., Malheiros D., Auler J., Ferreira A., Borsato M., Bezerra S., Gutierrez P., Caldini E., Pasqualucci C., Dolhnikoff M., Saldiva P. Lung pathology in fatal novel human influenza A (H1N1) infection. American Journal of Respiratory Cell and Molecular Biology 2010, 181:72-79.
48. Mukherjee S., Vipat V.C., Mishra A.C., Pawar S.D., Chakrabarti A.K. Pandemic (H1N1) 2009 influenza virus induces weaker host immune responses in vitro: a possible mechanism of high transmissibility. Virology Journal 2011, 8:140.
49. Nallagatla S.R., Toroney R., Bevilacqua P.C. RNA structure and regulation of innate immunity through protein kinase PKR. Current Opinion in Structural Biology 2011, 21:119.
50. Napolitano L., Park P, Sihler K., Papadimos T., Chenoweth C., Cinti S., Zalewski C., Sharangpani R., Somsel P., Wells E. Intensive-care patients with severe novel influenza A (H1N1) virus infection-Michigan, June 2009. MMWR Morbidity and Mortality Weekly Reports 2009, 58:749-752.
51. Nicoll A., Coulombier D. Europe's initial experience with pandemic (H1N1) 2009-mitigation and delaying policies and practices. Euro Surveill. 2009, 29. pii 19279, 14.
52. Paquette S.G., Banner D., Zhao Z., Fang Y., Huang S.S., Leon A.J., Ng D.C., Almansa R., Martin-Loeches I, Ramirez P., Socias L., Loza A, Blanco J., Sansonetti P., Rello J., Andaluz D., Shum B., Rubino S., de Lejarazu RO, Tran D, Delogu G., Fadda G., Krajden S., Rubin B.B, Bermejo-Martin JF, Kelvin AA, Kelvin DJ Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection. PLoS One 2012, 7:e38214.
53. Patel J.R., Vora K.P., Tripathi S., Zeng H., Tumpey T.M., Katz J.M., Sambhara S., Gangappa S. Infection of lung epithelial cells with pandemic 2009 A (H1N1) influenza viruses reveals isolate-specific differences in infectivity and host cellular responses. Viral Immunology 2011, 24:89-99.
54. Perez-Padilla R., de la Rosa-Zamboni D., Ponce de Leon S., Hernandez M., Quiñones-Falconi F., Bautista E., Ramirez-Venegas A., Rojas-Serrano J., Ormsby C.E., Corrales A., Higuera A., Mondragon E., Cordova-Villalobos J.A. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. New England Journal of Medicine 2009, 361:680-689.
55. Pica N., Hai R., Krammer F., Wang T.T., Maamary J., Eggink D., Tan G.S., Krause J.C., Moran T., Stein CR, Banach D., Wrammert J., Belshe R.B., Garcia-Sastre A., Palese P. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:2573-2578.
56. Rehwinkel J., Tan C.P., Goubau D., Schulz O., Pichlmair A., Bier K., Robb N., Vreede F., Barclay W., Fodor E., Reis e Sousa C. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010, 140:397-408.
57. Rowe T., León A.J., Crevar CJ, Carter D.M., Xu L., Ran L., Fang Y., Cameron C.M., Cameron M.J., Banner D., Ng DC, Ran R., Weirback H.K., Wiley C.A., Kelvin D.J., Ross T.M. Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology 2010, 401:257.
58. Saito T., Owen D.M., Jiang F., Marcotrigiano J., Gale M. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 2008, 454:523-527.
59. Samson M., Pizzorno A., Abed Y., Boivin G. Influenza virus resistance to neuraminidase inhibitors. Antiviral Research 2013, 98:174-185.
60. Sanders C.J., Doherty P.C., Thomas P.G. Respiratory epithelial cells in innate immunity to influenza virus infection. Cell and Tissue Research 2011, 343:13-21.
61. Shapira SD, Gat-Viks I., Shum B.O., Dricot A., de Grace M.M., Wu L., Gupta PB, Hao T, Silver S.J., Root D.E, Regev A., Hacohen N. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139:1255-1267.
62. Sharma K., Tripathi S., Ranjan P., Kumar P., Garten R., Deyde V., Katz JM, Cox N.J., Lal R.B., Sambhara S., Lal S. Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation. PLoS One 2011, 6:e20215.
63. Shieh W.-J., Blau D.M., Denison A.M., DeLeon-Carnes M., Adem P., Bhatnagar J., Sumner J., Liu L., Patel M, Batten B., Greer P., Jones T., Smith C., Bartlett J., Montague J., White E., Rollin D., Gao R., Seales C., Jost H., Metcalfe M., Goldsmith C.S., Humphrey C., Schmitz A., Drew C., Paddock C., Uyeki T.M., Zaki S.R. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. American Journal of Pathology 2010, 177:166-175.
64. Sieczkarski S.B., Brown H.A., Whittaker G.R. Role of protein kinase C βII in influenza virus entry via late endosomes. Journal of Virology 2003, 77:460-469.
65. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annual Review of Biochemistry 2000, 69:531-569.
66. Suksatu A., Sangsawad W., Thitithanyanont A., Smittipat N., Fukuda M.M., Ubol S. Characteristics of stork feces-derived H5N1 viruses that are preferentially transmitted to primary human airway epithelial cells. Microbiology and Immunology 2009, 53:675-684.
67. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
68. Tam A., Wadsworth S., Dorscheid D., Man S.P., Sin D.D. The airway epithelium: more than just a structural barrier. Therapeutic Advances in Respiratory Disease 2011, 5:255-273.
69. Taniguchi T., Ogasawara K., Takaoka A., Tanaka N. IRF family of transcription factors as regulators of host defense. Annual Review of Immunology 2001, 19:623-655.
70. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annual Review of Pathology 2008, 3:499.
71. Teijaro J.R., Walsh K.B., Cahalan S., Fremgen D.M., Roberts E., Scott F., Martinborough E., Peach R., Oldstone M., Rosen H. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 2011, 146:980-991.
72. Uyeki T.M., Sharma A., Branda J.A. Case 40-2009: a 29-year-old man with fever and respiratory failure. New England Journal of Medicine 2009, 361:2558-2569.
73. Wang J.P., Bowen G.N., Padden C., Cerny A., Finberg R.W., Newburger P.E., Kurt-Jones E.A. Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood 2008, 112:2028-2034.
74. Whitley R.J., Boucher C.A., Lina B., Nguyen-Van-Tam J.S., Osterhaus A., Schutten M., Monto A.S. Global Assessment of Resistance to Neuraminidase Inhibitors: 2008-2011. The Influenza Resistance Information Study (IRIS). Clinical Infectious Diseases 2013, 56:1197-1205.
75. Xu W., Chen M., Ge N., Xu J. Hemagglutinin from the H5N1 virus activates janus kinase 3 to dysregulate innate immunity. PLoS One 2012, 7:e31721.
76. Yamashita K., Imaizumi T., Taima K., Fujita T., Ishikawa A., Yoshida H., Oyama C., Satoh K. Polyinosinic-polycytidylic acid induces the expression of GRO-α in BEAS-2B cells. Inflammation 2005, 29:17-21.
77. Zeng H., Pappas C., Katz J.M., Tumpey T.M. The 2009 pandemic H1N1 and triple-reassortant swine H1N1 influenza viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells. Journal of Virology 2011, 85:686-696.
78. Zhang Z., Kim T., Bao M., Facchinetti V, Jung S.Y., Ghaffari AA, Qin J., Cheng G, Liu Y.-J. DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity 2011, 34:866-878.
79. Zheng X., Bevilacqua P.C. Activation of the protein kinase PKR by short double-stranded RNAs with single-stranded tails. RNA 2004, 10:1934-1945.